Skip to Content
Discovering the causes of cancer and the means of prevention

Prostate Cancer Genome-Wide Association Study (GWAS)

From the Cancer Genetic Markers of Susceptibility (CGEMS) Project

The Cancer Genetic Markers of Susceptibility (CGEMS) prostate cancer genome-wide association study (GWAS) included genotyping approximately 550,000 SNPs (Phase 1A with HumanHap300 and Phase 1B HumanHap240, both from Illumina, San Diego, CA) in 1,172 prostate cancer patients and 1,157 controls of European ancestry from the Prostate, Lung, Colon and Ovarian (PLCO).  The original analysis published in Nature Genetics [PMID: 17401363] included 2,282 subjects. After improvement and revisions of the original analysis, 2,252 subjects were submitted to dbGaP.

Obtain additional information or apply for access to the Prostate Cancer Genome-Wide Association Study.